Form 4: Cardio Diagnostics Holdings Director Robert Philibert Increases Stake in Company

Robert Philibert, Chief Medical Officer and Director of Cardio Diagnostics Holdings, recently acquired additional shares of common stock through indirect ownership.

Summary

• On September 6, 2024, Robert Philibert, a Director and the Chief Medical Officer of Cardio Diagnostics Holdings, acquired 26,615 shares of common stock at a price of $0.287 per share.
• On the same day, Philibert also acquired 7,460 shares of common stock at a price of $0.2848 per share.
• Following these transactions, Philibert indirectly beneficially owns 1,683,867 shares.
• These shares are held through BD Holding Inc. (1,586,464 shares), Behavioral Diagnostics LLC (14,126 shares), his spouse (7,601 shares), and directly (75,676 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The insider buying could indicate confidence, but it's not a major transaction.

Positives

• The increased stake by a director and officer could be seen as a positive signal about their confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. An increase in holdings by a key executive is often viewed positively.

Stakeholder Impact

• The increased stake by a director could positively influence shareholder sentiment.

Key Dates